Crypto Updates

Cathie Wood’s Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam

Veteran Trader Peter Brandt Asks Macro Guru If Bitcoin Bull Has Finally Awoken From Deep Slumber

Cathie Wood-led Ark Invest made a notable move in the market by selling a significant portion of its Coinbase Global Inc (NASDAQ:COIN) shares on Tuesday. This decision comes as cryptocurrencies, including Bitcoin, experience a downturn, prompting a strategic shift in Ark Invest’s portfolio.

The Coinbase Trade

On Tuesday, Ark sold a total of 82,255 Coinbase shares worth $11.48 million through ARK Innovation ETF (NYSE:ARKK), ARK Next Generation Internet ETF (NYSE:ARKW) and Ark Fintech Innovation ETF (NYSE:ARKF). On the day Coinbase shares closed 1.2% higher at $139.62.

Ark Invest’s decision to reduce its holdings in Coinbase is particularly significant given the recent market trends. According to Benzinga’s coverage, Coinbase co-founder Fred Ehrsam and Ark Invest collectively offloaded over $14 million in COIN shares over 48 hours leading up to Tuesday. Until that time Ark had reported a sale of $100 million worth of COIN shares in December.

Ark’s moves seemingly align with the broader market sentiment where cryptocurrencies are facing a phase of uncertainty. Ark’s sale of Coinbase shares is part of a larger trend of divesting from crypto-related assets, as seen in their recent sale of Grayscale Bitcoin Trust shares.

Other Key Trades:

Ark Invest bought 91,635 shares of Toast Inc (NYSE:TOST) through ARKF and 112,742 shares through ARKW, indicating a growing interest in this technology-driven company.
The firm also increased its stake in CRISPR Therapeutics AG (NASDAQ:CRSP) by purchasing 12,108 shares, reflecting confidence in the biotech sector through ARK Genomic Revolution ETF (NYSE:ARKG) and 52,287 shares through ARKK.
Significant investments were made in Adaptive Biotechnologies (NASDAQ:ADPT), with 146,414 shares added via ARKG, showcasing Ark’s focus on innovative medical technologies.
Another notable buy was in 10X Genomics Inc (NASDAQ:TXG), with 5,914 shares acquired through ARKG and a further 3,892 shares through ARKK, further diversifying Ark’s portfolio in the biotech space.

See Also: Cathie Wood Predicts Bitcoin Could Rise To $1.5M

Ark Invest’s recent trades, especially the sale of Coinbase shares, highlight the fund’s adaptive strategy in response to the dynamic crypto market. As the investment landscape continues to evolve, Ark’s moves offer valuable…

Click Here to Read the Full Original Article at Cryptocurrencies Feed…